LMC Optometry Update – Clinic Reopenings
COVID UPDATE Thank you in advance for your patience as we navigate this new normal! Your health is our priority which is why we are working diligently in putting new health and safety protocols in place. Our goal is to accommodate everyone as quickly as we can while...
LMC Healthcare Updates and Preparation for Your Upcoming Appointment
Covid-19 has surely impacted every Canadian and every healthcare facility in Canada. At LMC Healthcare we remain dedicated to Making Healthy Easier for our patients. Here’s an overview of the services available at this time: LMC Healthcare Provider / Service Virtual...
COVID-19 Optometry Update
Brampton: closed March 18 Please note, in an effort to prevent the spread of the Coronavirus we have been advised by the College of Optometry to close our clinic. We will offer emergency appointments at our Thornhill clinic located at 1600 Steeles Avenue West from...
COVID-19 Update From LMC
Dear LMC Patients, In these challenging times, we would like to assure you that your health and safety, as well as that of our healthcare providers and staff remain our top priority. LMC's management team is continuously monitoring and responding to Public Health...
LMC Pharmacy Completes Acquisition of Diabetes Depot
Toronto, Ontario, November 18, 2019 – LMC Pharmacy announced today that it has completed the acquisition of Diabetes Depot – Canada’s original “one-stop-shop” for insulin pump supplies. “Today’s announcement marks an important milestone for LMC Pharmacy and Diabetes...
Leading Diabetes Organizations Call for Urgent Action to End Diabetes in Canada
Diabetes Canada, JDRF Canada and LMC Healthcare hosted an event on World Diabetes Day, November 14, to raise awareness about type 1 and type 2 diabetes and advocate for more urgent action to address the disease in Canada. Diabetes now affects over a third of...
LMC and Diabetes Canada Team Up to launch Canadian Diabetes Prevention Program
Brampton, ON, June 25, 2019: Today, 1 in 9 adults aged 20 and older—more than three million Canadians—lives with diagnosed diabetes. Approximately 90% of these cases are type 2 diabetes, which is a preventable form of diabetes for many Canadians. Although diabetes...
First assessment of the performance of an implantable continuous glucose monitoring system through 180 days in a primarily adolescent population with type 1 diabetes
This month, our newest publication is the full report of the Eversense study results. Eversense is the very nifty sensor that is implanted subcutaneously and provides continuous glucose monitoring to your phone for 6 months. Our results were in teenagers...
Patients, data, and making it all work together: Using RWD in research
Using RWD and RWE to make data actionable and patient centric can be a gamechanger in the health care industry's research capabilities. During ACRP 2019, Karri Venn, president of research at LMC Manna, gave a talk regarding real world data (RWD) and real...
RESEARCH SPOTLIGHT: Insulin glargine/lixisenatide fixed-ratio combination improves glycaemic variability and control without increasing hypoglycaemia
LMC Manna Research’s Chief Medical officer Dr. Ronnie Aronson shares our latest publication showcasing our collaborative work with the medications lixisenatide and LixiLan (lixisenatide & lantus combination) over the past decade. This publication is a...